• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD INLAY URETERAL STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 BARD INLAY URETERAL STENT Back to Search Results
Model Number 778424
Device Problem Material Fragmentation (1261)
Patient Problems Foreign Body In Patient (2687); Patient Problem/Medical Problem (2688); No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event Description
It was reported that upon inserting ureteral stent pusher into nipple on 22f sheath, orange shavings from pusher was observed and removed from bladder.It was later reported from the sales rep.Via email on 31mar2020, the doctor left the sheath in and let the pieces/shavings drain out.
 
Manufacturer Narrative
The reported event was confirmed however the cause was unknown.Sample received consisted of a orange pusher and with some orange fragments found within the ziploc bag.The returned sample has chatter marks down one side of the part with the od of the sample not pinched or structurally damaged.Chatter marks are in a consistent pattern and can be seen at 12'-18' with an unaided eye.The chatter marks can easily be felt be felt with little pressure.The root cause was unknown.A potential root cause was a defective push catheter that was missed during incoming inspection due to an operator not following inspection procedure.The device history record was reviewed and found nothing that could have caused or contributed to the reported event.The instructions for use were found adequate and state the following: "indications for use: the bard® inlay¿ and bard® inlay¿ versafit¿ ureteral stent with suture are indicated to relieve obstruction in a variety of benign, malignant and post-traumatic conditions in the ureter such as presence of stones and/or stone fragments, or other ureteral obstructions such as those associated with ureteral stricture, carcinoma of abdominal organs, retroperitoneal fibrosis or ureteral trauma, or in association with extracorporeal shock wave lithotripsy (eswl).The stent may be placed using endoscopic surgical techniques or percutaneously using standard radiographic technique.Contraindications: there are no known contraindications to use.Precautions: 1.For single use only.Do not resterilize.Do not use if the package or product is damaged.2.Improper handling technique can seriously weaken the stent.Acute bending or overstressing during placement could result in subsequent separation of the stent at the point of stress after a prolonged indwelling period.3.Suture may be cut off prior to stent placement.Remove suture prior to placement for pediatric patients.4.Exercise care.Tearing of the stent can be caused by sharp instruments.5.Ureteral stents should be checked periodically for signs of encrustation and proper function.Periodic checks of the stent by cystoscopic and/or radiographic procedures are recommended at intervals deemed to be appropriate by the physician in consideration of the individual patient¿s condition and other patient specific factors.When long-term use is indicated, it is recommended that indwelling time not exceed 365 days.The stent is not intended as a permanent indwelling device.6.Care should be exercised when removing the stent from inner polybag so as not to cause tearing or fragmentation.7.With any ureteral stent, migration is a possible complication which could require medical intervention for removal.Selection of too short a stent may result in migration.8.The insertion of a ureteral stent should only be done by those individuals who have comprehensive training in the techniques and risks of the procedure.9.Multi-length ureteral stents: formation of knots in multi-length ureteral stents may occur.This may result in injury to the ureter during removal and/or the need for additional surgical intervention.The presence of a knot should be considered if significant resistance is encountered during attempts at removal.".
 
Event Description
It was reported that upon inserting ureteral stent pusher into nipple on 22f sheath, orange shavings from pusher was observed and removed from bladder.It was later reported from the sales rep.Via email on 31mar2020, the doctor left the sheath in and let the pieces/shavings drain out.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD INLAY URETERAL STENT
Type of Device
URETERAL STENT
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
MDR Report Key9962308
MDR Text Key188202006
Report Number1018233-2020-02593
Device Sequence Number1
Product Code FAD
UDI-Device Identifier00801741014758
UDI-Public(01)00801741014758
Combination Product (y/n)N
PMA/PMN Number
K983498
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 08/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/23/2023
Device Model Number778424
Device Catalogue Number778424
Device Lot NumberNGDV1543
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/10/2020
Initial Date Manufacturer Received 03/26/2020
Initial Date FDA Received04/15/2020
Supplement Dates Manufacturer Received08/11/2020
Supplement Dates FDA Received08/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-